Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone implant for alcohol use disorder
CTR20222972Phase 2Completed
- Sponsor
- Shenzhen Sciencare Medical Industries Co., Ltd.
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in alcohol use disorder (AUD), sponsored by Shenzhen Sciencare Medical Industries Co., Ltd.. Started Nov 2022; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on CTR20222972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222972.